Phenotypic variability in ALS-FTD and effect on survival
Abstract
Objective
Methods
Results
Conclusions
Get full access to this article
View all available purchase options and get full access to this article.
References
Information & Authors
Information
Published In
Copyright
Publication History
Disclosure
Study Funding
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches, International Journal of Molecular Sciences, 25, 4, (2320), (2024).https://doi.org/10.3390/ijms25042320
- Unraveling the Heterogeneity of ALS—A Call to Redefine Patient Stratification for Better Outcomes in Clinical Trials, Cells, 13, 5, (452), (2024).https://doi.org/10.3390/cells13050452
- Risk factors for the neurodegenerative dementias in the Western Pacific region, The Lancet Regional Health - Western Pacific, 50, (101051), (2024).https://doi.org/10.1016/j.lanwpc.2024.101051
- Metabolite alterations in the left dorsolateral prefrontal cortex and its association with cognitive assessments in amyotrophic lateral sclerosis: A longitudinal magnetic resonance spectroscopy study, Brain Research Bulletin, 219, (111125), (2024).https://doi.org/10.1016/j.brainresbull.2024.111125
- Corticobasal Syndrome (CBS), Movement Disorders Phenomenology, (199-236), (2024).https://doi.org/10.1007/978-3-031-52573-5_6
- Cognitive disorders in amyotrophic lateral sclerosis, Neurology, Neuropsychiatry, Psychosomatics, 15, 2, (68-74), (2023).https://doi.org/10.14412/2074-2711-2023-2-68-74
- Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia, Science Advances, 9, 18, (2023).https://doi.org/10.1126/sciadv.ade2044
- Severity of in vivo corticospinal tract degeneration is associated with survival in amyotrophic lateral sclerosis: a longitudinal, multicohort study, European Journal of Neurology, 30, 5, (1220-1231), (2023).https://doi.org/10.1111/ene.15686
- Prognostic value of motor and extramotor involvement in ALS, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 25, 1-2, (67-74), (2023).https://doi.org/10.1080/21678421.2023.2284899
- MRI biomarkers for memory-related impairment in amyotrophic lateral sclerosis: a systematic review, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24, 7-8, (572-588), (2023).https://doi.org/10.1080/21678421.2023.2236651
- See more
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.
We thank Dr. Abe for his interest in our study1 that investigated survival in amyotrophic lateral sclerosis-frontotemporal dementia (ALS- FTD) patients. Specific comparison of motor and cognitive presentations in ALS-FTD established that patients with a motor-onset of their disease had reduced survival—which was associated with increased motor cortex atrophy—suggesting that survival may be mediated by motor function and other critical physiological aspects.
We agree that ALS-FTD can present with behavioral and cognitive changes, as has been documented in well-characterized case series.2–4
A key aim of the present study was to understand how this cognitive, behavioral profile differs from behavioral variant frontotemporal dementia (bvFTD). We found that those with ALS-FTD with an initial cognitive presentation have more prominent language changes and both ALS-FTD motor and cognitive presentation have greater deficits in emotion processing than bvFTD—which is a new finding and requires further investigation—as traditionally bvFTD has been regarded as having the greatest emotion processing deficits.5
Further studies are currently underway to better dissect the presentations and phenotypes across the ALS-FTD spectrum. Such studies should include both clinical, structural, functional, and pathological evaluation to better characterize the commonalities and differences across the ALS-FTD spectrum.
Disclosure
The authors report no relevant disclosures. Contact [email protected] for full disclosures.
References
I read the article by Ahmed et al.1 and generally agree with their comments. However, I offer some insights.
First, Yuasa2 reported a case of amyotrophic lateral sclerosis (ALS) with dementia who presented impairment of personality, forgetfulness, and forced grasp before presenting muscle weakness. The patient showed brain atrophy in the frontal lobe. Following reports—including autopsies and neuroimages that supported ALS with dementia or motor neuron disease (MND) with dementia—showed atrophy, reduced blood flow, or hypometabolism characterized demonstrated in the central region and in the frontal lobe. The authors suggested that emotion processing and behavior disturbance had been considered core deficits in behavioral variant frontotemporal dementia (bvFTD) and thought to be less prominent in ALS-FTD. However, other studies including Yuasa’s suggested behavioral changes in ALS-FTD patients in their early stages. To elucidate these differences, morphological study does not have enough power, but functional imaging studies may hold advantages.3 We studied ALS patients with dementia by using SPECT and concluded ALS and ALS with dementia made a wide spectrum of a disease.4 The authors’ indication of atrophy in the dorsolateral prefrontal cortex (DLPFC) might be a key for differential diagnoses of variant types of ALS-FTD. I recently experienced an ALS-FTD patient who showed dominant bulbar palsy with forgetfulness but preserved personality. His SPECT showed reduced uptake in the central and prefrontal cortex not in the DLPFC.
I agree that further studies of ALS, ALS-FTD, and bvFTD are needed, but I suggest that function studies should be included in future projects.
Disclosure
The author reports no relevant disclosures. Contact [email protected] for full disclosures.
References